Ronald Griffith

Ronald Griffith is a highly experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the Director and Chief Science Officer at LuTran Inc. since April 2014. Additionally, Ronald operates as a Principal at RG Pharmaceutical Consulting, focusing on drug discovery, medicinal chemistry, DMPK, and preclinical development for various companies. Prior experience includes roles as Chief Scientific Officer and VP of Research at Genelabs Technologies from 2001 to 2010, VP of Chemistry at Tanabe Seiyaku Co LTD from 1997 to 2000, and Executive Director of Chemistry at AstraZeneca from 1974 to 1997. Ronald holds a Ph.D. in Organic Chemistry from Syracuse University and has completed a postdoctoral research fellowship at Caltech.